BACKGROUND: Hair loss is a prevalent medical problem in both men and women. Maintaining the potential hair inductivityof dermal papilla cells (DPCs) during cell culture is the main factor in hair follicle morphogenesis and regeneration. Thepresent study was conducted to compare the effects of different concentrations of human hair outer root sheath cell(HHORSC)and platelet lysis (PL) exosomes to maintain hair inductivity of the human dermal papilla cells (hDPCs). METHODS: In this study, hDPCs and HHORSCswere isolated from healthy hair samples. Specific markers of hDPCs (versican,a-SMA) and HHORSCs (K15) were evaluated using flow cytometric and immunocytochemical techniques. The exosomes wereisolated fromHHORSCsand PL with ultracentrifugation technique.Western blot was used to detect specific markers of HHORSCsand PL exosomes. Particle size and distribution of the exosomes were analyzed by NanoSight dynamic light NanoSight DynamicLight Scattering. Different methods such as proliferation test (MTS assay), migration test (Transwell assay) were used to evaluatethe effects of different concentrations of exosomes (2,550,100 lg/ml) derived from HHORSC and PL on hDPCs. Expression ofspecific genes in the hair follicle inductivity, including ALP, versican and a-SMA were also evaluated using real time-PCR. RESULTS: The flow cytometry of the specific cytoplasmic markers of the hDPCs and HHORSCs showed expression ofversican (77%), a-SMA (55.2%) and K15 (73.2%). The result of particle size and distribution of the exosomes wereanalyzed by NanoSight dynamic light NanoSight Dynamic Light Scattering, which revealed the majority of HHORSC andPL exosomes were 30–150 nm. For 100 lg/ml of HHORSC exosomes, the expressions of ALP, versican and a-SMAproteins respectively increased by a factor of 2.1, 1.7and 1.3 compared to those in the control group. CONCLUSION In summary, we applied HHORSC exosomes as a new method to support hair inductivity of dermalpapilla cells and improve the outcome for the treatment of hair loss.

BACKGROUND: Hair loss is a prevalent medical problem in both men and women. Maintaining the potential hair inductivityof dermal papilla cells (DPCs) during cell culture is the main factor in hair follicle morphogenesis and regeneration. Thepresent study was conducted to compare the effects of different concentrations of human hair outer root sheath cell(HHORSC)and platelet lysis (PL) exosomes to maintain hair inductivity of the human dermal papilla cells (hDPCs). METHODS: In this study, hDPCs and HHORSCswere isolated from healthy hair samples. Specific markers of hDPCs (versican,a-SMA) and HHORSCs (K15) were evaluated using flow cytometric and immunocytochemical techniques. The exosomes wereisolated fromHHORSCsand PL with ultracentrifugation technique.Western blot was used to detect specific markers of HHORSCsand PL exosomes. Particle size and distribution of the exosomes were analyzed by NanoSight dynamic light NanoSight DynamicLight Scattering. Different methods such as proliferation test (MTS assay), migration test (Transwell assay) were used to evaluatethe effects of different concentrations of exosomes (2,550,100 lg/ml) derived from HHORSC and PL on hDPCs. Expression ofspecific genes in the hair follicle inductivity, including ALP, versican and a-SMA were also evaluated using real time-PCR. RESULTS: The flow cytometry of the specific cytoplasmic markers of the hDPCs and HHORSCs showed expression ofversican (77%), a-SMA (55.2%) and K15 (73.2%). The result of particle size and distribution of the exosomes wereanalyzed by NanoSight dynamic light NanoSight Dynamic Light Scattering, which revealed the majority of HHORSC andPL exosomes were 30–150 nm. For 100 lg/ml of HHORSC exosomes, the expressions of ALP, versican and a-SMAproteins respectively increased by a factor of 2.1, 1.7and 1.3 compared to those in the control group. CONCLUSION In summary, we applied HHORSC exosomes as a new method to support hair inductivity of dermalpapilla cells and improve the outcome for the treatment of hair loss.

To discuss the advantages and limitations of hair follicle-derived cell transplantation (FCT) in vitiligo, compared to the epidermal cell transplantation (ECT), and the knowledge gap which is required to be bridged. The papers relevant to the purpose was reviewed. Surgical approaches for treating vitiligo are based on the idea of replenishing lost melanocytes.Skin and hair follicles as the main sources of melanocytes have been applied for this purpose transferring the whole tissue or tissue-derived cell suspension to the vitiligo lesions. Considering the differences between hair follicle and epidermis in terms of the constituting cell populations, phenotype and function of melanocytes, and micro-environmental factors, different response of vitiligo patients to treatment with FCT or ECT would be expected theoretically. However, there is currently a lack of evidence on such a difference. However, ECT appears to be a more feasible, less time-consuming, and more comfortable treatment for both physicians and patients. Although the current evidence has not shown a significant difference between ECT and FCT in terms of efficacy, ECT appears to be more feasible specifically in the treatment of large lesions. However, further randomized controlled clinical trials with larger sample sizes and longer follow-up durations are required to be conducted to draw a definite conclusion on comparing FCT with ECT in terms of the safety, efficacy, durability of the therapeutic effects, and indications in vitiligo patients.

To discuss the advantages and limitations of hair follicle-derived cell transplantation (FCT) in vitiligo, compared to the epidermal cell transplantation (ECT), and the knowledge gap which is required to be bridged. The papers relevant to the purpose was reviewed. Surgical approaches for treating vitiligo are based on the idea of replenishing lost melanocytes.Skin and hair follicles as the main sources of melanocytes have been applied for this purpose transferring the whole tissue or tissue-derived cell suspension to the vitiligo lesions. Considering the differences between hair follicle and epidermis in terms of the constituting cell populations, phenotype and function of melanocytes, and micro-environmental factors, different response of vitiligo patients to treatment with FCT or ECT would be expected theoretically. However, there is currently a lack of evidence on such a difference. However, ECT appears to be a more feasible, less time-consuming, and more comfortable treatment for both physicians and patients. Although the current evidence has not shown a significant difference between ECT and FCT in terms of efficacy, ECT appears to be more feasible specifically in the treatment of large lesions. However, further randomized controlled clinical trials with larger sample sizes and longer follow-up durations are required to be conducted to draw a definite conclusion on comparing FCT with ECT in terms of the safety, efficacy, durability of the therapeutic effects, and indications in vitiligo patients.